Simultaneously, cytokine-mediated suppression of ferroportin, through both hepcidin-dependent degradation and transcriptional repression, limits iron efflux from enterocytes and macrophages, leading to hypoferremia and anemia of chronic disease [198,200]. This evidence concerns the gene SLC40A1 and anemia.